Your browser doesn't support javascript.
loading
First-line Afatinib in Patients With Non-small-cell Lung Cancer With Uncommon EGFR Mutations in South Korea.
Kim, Mi-Hyun; Choi, Chang Min; Lee, Sung Yong; Park, Cheol Kyu; Chang, Yoon Soo; Lee, Kye Young; Kim, Seung Joon; Yang, Sei Hoon; Ryu, Jeong Seon; Lee, Jeong Eun; Lee, Shin Yup; Park, Chan Kwon; Lee, Sang Hoon; Jang, Seung Hun; Yoon, Seong Hoon; Jang, Tae Won.
Affiliation
  • Kim MH; Department of Internal Medicine, Pusan National University School of Medicine and Βiomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.
  • Choi CM; Department of Internal Medicine, Ulsan University Asan Medical Center, Seoul, Republic of Korea.
  • Lee SY; Department of Internal Medicine, Division of Pulmonology, Allergy, and Critical Care Medicine, Korea University Guro Hospital, Seoul, Republic of Korea.
  • Park CK; Department of Internal Medicine, Chonnam National University Hwasun Hospital, Hwasun, Republic of Korea.
  • Chang YS; Department of Internal Medicine, Yonsei University Gangnam Severance Hospital, Seoul, Republic of Korea.
  • Lee KY; Department of Internal Medicine, Konkuk University Medical Center, Seoul, Republic of Korea.
  • Kim SJ; Department of Internal Medicine, Catholic University Seoul St. Mary's Hospital, Seoul, Republic of Korea.
  • Yang SH; Department of Internal Medicine, Wonkwang University Hospital, Iksan, Republic of Korea.
  • Ryu JS; Department of Internal Medicine, Inha University Hospital, Incheon, Republic of Korea.
  • Lee JE; Department of Internal Medicine, Chungnam National University, Daejeon, Republic of Korea.
  • Lee SY; Department of Internal Medicine, Kyungpook National University Chilgok Hospital, Daegu, Republic of Korea.
  • Park CK; Department of Internal Medicine, Catholic University Yeoudo St. Mary's Hospital, Seoul, Republic of Korea.
  • Lee SH; Department of Internal Medicine, Yonsei University Severance Hospital, Seoul, Republic of Korea.
  • Jang SH; Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea.
  • Yoon SH; Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea.
  • Jang TW; Department of Internal Medicine, Kosin University College of Medicine, Kosin University Gospel Hospital, Busan, Republic of Korea jangtw22@hanmail.net.
Anticancer Res ; 42(3): 1615-1622, 2022 Mar.
Article in En | MEDLINE | ID: mdl-35220259
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Carcinoma, Non-Small-Cell Lung / Protein Kinase Inhibitors / Afatinib / Lung Neoplasms / Mutation / Antineoplastic Agents Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Anticancer Res Year: 2022 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Carcinoma, Non-Small-Cell Lung / Protein Kinase Inhibitors / Afatinib / Lung Neoplasms / Mutation / Antineoplastic Agents Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Anticancer Res Year: 2022 Document type: Article